Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Sonnet BioTherapeutics Holdings Inc’s stock clocked out at $1.46, down -1.35% from its previous closing price of $1.48. In other words, the price has decreased by -$1.35 from its previous closing price. On the day, 0.14 million shares were traded. SONN stock price reached its highest trading level at $1.54 during the session, while it also had its lowest trading level at $1.445.
Ratios:
To gain a deeper understanding of SONN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.66 and its Current Ratio is at 0.66.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SONN now has a Market Capitalization of 4390848 and an Enterprise Value of -2229971. For the stock, the TTM Price-to-Sale (P/S) ratio is 219.49. Its current Enterprise Value per Revenue stands at -39.906 whereas that against EBITDA is 0.182.
Stock Price History:
Over the past 52 weeks, SONN has reached a high of $18.72, while it has fallen to a 52-week low of $1.41. The 50-Day Moving Average of the stock is -51.55%, while the 200-Day Moving Average is calculated to be -82.24%.
Shares Statistics:
It appears that SONN traded 1.34M shares on average per day over the past three months and 229180 shares per day over the past ten days. A total of 3.01M shares are outstanding, with a floating share count of 2.87M. Insiders hold about 4.41% of the company’s shares, while institutions hold 0.01% stake in the company. Shares short for SONN as of 1732838400 were 40115 with a Short Ratio of 0.16, compared to 1730332800 on 66231. Therefore, it implies a Short% of Shares Outstanding of 40115 and a Short% of Float of 4.8499998.
